Abstract
Multisystem inflammatory syndrome in adults (MIS-A) is a rare and emerging syndrome after coronavirus disease 2019 (COVID-19). To the best of our knowledge, Japanese cases of MIS-A are rarely reported. Here, we describe a case of MIS-A in a 44-year-old Japanese woman presenting with multiorgan dysfunction (i.e., cardiovascular and mucocutaneous involvement) and markedly elevated inflammatory markers 2 weeks after recovery from COVID-19. Treatment with intravenous immunoglobulins and corticosteroids resolved her symptoms. On the 13th day, she was discharged from the hospital with no recurrences on follow-up. This study highlights the importance of recognizing this emerging syndrome when treating patients with multiorgan dysfunction after COVID-19.
Keywords: COVID-19; Multisystem inflammatory syndrome; SARS-CoV-2.
【저자키워드】 COVID-19, SARS-CoV-2, Multisystem inflammatory syndrome, 【초록키워드】 Corticosteroid, coronavirus disease, SARS-CoV-2, Intravenous immunoglobulin, knowledge, hospital, Symptoms, Patient, Inflammatory marker, Follow-up, Japanese, Inflammatory, Multiorgan dysfunction, syndrome, highlight, reported, elevated, recognizing, discharged, presenting, resolved, 【제목키워드】 coronavirus disease, Case report, Japanese, Inflammatory, syndrome,